| Monoclonal antibody successes in the clinic
| [0011]
|
| The therapeutic antibodies market to 2008
| [0011]
|
| Monoclonal antibodies: versatile platforms for cancer immunotherapy
| [0011]
|
| Differential responses of human tumor cell lines to anti-pl 85HER2 monoclonal antibodies
| [0011]
|
| ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas
| [0011]
|
| Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies
| [0011]
|
| Optimizing engagement of the immune system by anti-tumor antibodies: an engineer's perspective
| [0011]
|
| Antibody-drug conjugates: targeted drug delivery for cancer
| [0011]
|
| Teaching antibodies to engage T-cells for cancer therapy
| [0011]
|
| T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells
| [0011]
|
| Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma
| [0011]
|
| Ipilimumab in the treatment of melanoma
| [0011]
|
| IPILIMUMAB - A NOVEL IMMUNOMODULATING THERAPY CAUSING AUTOIMMUNE HYPOPHYSITIS: A CASE REPORT AND REVIEW
| [0011]
|
| The Japanese experience with biologic therapies for rheumatoid arthritis
| [0011]
|
| Ann. Rheum. Dis.
| [0011]
|
| Antibody engineering for the development of therapeutic antibodies
| [0011]
|
| Tumor-specific activation of an EGFR-targeting probody enhances therapeutic index
| [0011]
|
| Probody therapeutics for targeting antibodies to diseased tissue
| [0011]
|
| Proc. Natl. Acad. Sci. USA
| [0019]
|
| Annu. Rev. Biophys. Biomol. Struct.
| [0019]
|
| Proc. Natl. Acad. Sci. U.S.A.
| [0019]
|
| Kuby Immunology
| [0025]
|
| J. Mol. Biol.
| [0026]
|
| Sequences of Proteins of Immunological Interest
| [0026]
[0029]
|
| J. Mol. Biol.
| [0026]
|
| J Biol Chem.
| [0033]
|
| Methods in Molecular Biology
| [0039]
|
| Biochimica et Biophysica Acta - Proteins and Proteomics
| [0039]
|
| Journal of Applied Microbiology
| [0039]
|
| Journal of Biomolecular Screening
| [0039]
|
| Journal of Biological Chemistry
| [0039]
|
| AIDS
| [0039]
|
| J. Immunol.
| [0042]
|
| Methods in Molecular Biology
| [0047]
|
| J. Mol. Biol.
| [0053]
[0054]
|
| Methods Enzymol.
| [0054]
|
| Antibodies: A Laboratory Manual
| [0056]
|
| J Clin Invest.
| [0091]
|
| Antibodies
| [0091]
[0272]
|
| J Pharm Sci.
| [0092]
|
| J Inflamm (Lond)
| [0108]
|
| Nat Rev Immunol.
| [0108]
|
| Nat Rev Drug Discov.
| [0108]
|
| Respir Res.
| [0108]
|
| Dis Model Mech.
| [0108]
|
| Biochim Biophys Acta
| [0108]
|
| Nat Rev Cancer.
| [0109]
|
| PNAS
| [0110]
|
| Nat Rev Drug Discov.
| [0110]
|
| Nature Biotechnology
| [0127]
|
| PNAS
| [0129]
|
| Biochemical Journal
| [0129]
|
| Beilstein J Nanotechnol.
| [0129]
|
| J. Mol. Biol.
| [0146]
|
| Mol Cell Biol.
| [0205]
|
| Current protocols in Molecular Biology edit
| [0205]
[0206]
|
| Nat Biotechnol.
| [0237]
|
| Nucleic Acids Res.
| [0237]
|
| Proc Natl Acad Sci U S A.
| [0237]
|
| Proc Natl Acad Sci U S A.
| [0237]
|
| Protein Eng Des Sel.
| [0237]
|
| Proc Natl Acad Sci U S A.
| [0237]
|
| MAbs
| [0237]
|
| Methods Mol Biol.
| [0237]
|
| The Chinese-German Journal of Clinical Oncology
| [0264]
|
| Blood
| [0266]
[0272]
|
| J. Immunol.
| [0278]
|
| J. Immunol. Methods.
| [0310]
[0323]
|
| J. Immunol. Methods
| [0310]
[0323]
|
| Biotechnol. Prog.
| [0310]
[0323]
|
| Mol. Cell Proteomics
| [0310]
[0323]
|
| Journal of Molecular Biology
| [0333]
|
| J. Immunol. Methods
| [0333]
|